ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617989 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617989; 2) Community: the network communities that were significantly associated with the response to NSC 617989; 3) Molecule: the relationships between components within communities and NSC 617989; 4) MDR: the compounds that were significantly associated with the NSC 617989.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00457614317494024 0.35563122
NSC 72961 8-Azadenosine 0.00457614317494024 0.3035259
NSC 740 Methotrexate 0.00457614317494024 0.42134183
NSC 744063 Null 0.00457614317494024 0.39102112
NSC 748715 Null 0.00457614317494024 0.33056576
NSC 762559 Null 0.00457614317494024 -0.35228655
NSC 87222 ACTINOMYCIN C3 0.00457614317494024 0.42943996
NSC 100290 Doxypyrromycin hydrochloride 0.00479683626511385 0.43147219
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.00479683626511385 0.51714644
NSC 243022 Cinerubin A hydrochloride 0.00479683626511385 0.44369938
Total:184  Current:35    [First] [Prev] [Next] [Last]